- Home
- PRKS vs ZLAB Comparison
PRKS vs ZLAB Comparison
Compare PRKS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- ZLAB
- Stock Information
- Founded
- PRKS 1959
- ZLAB 2013
- Country
- PRKS United States
- ZLAB China
- Employees
- PRKS N/A
- ZLAB N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- ZLAB Health Care
- Exchange
- PRKS Nasdaq
- ZLAB Nasdaq
- Market Cap
- PRKS 2.8B
- ZLAB 3.2B
- IPO Year
- PRKS 2013
- ZLAB 2017
- Fundamental
- Price
- PRKS $51.25
- ZLAB $25.41
- Analyst Decision
- PRKS Buy
- ZLAB Buy
- Analyst Count
- PRKS 10
- ZLAB 6
- Target Price
- PRKS $56.40
- ZLAB $57.22
- AVG Volume (30 Days)
- PRKS 684.0K
- ZLAB 668.1K
- Earning Date
- PRKS 11-06-2025
- ZLAB 11-06-2025
- Dividend Yield
- PRKS N/A
- ZLAB N/A
- EPS Growth
- PRKS N/A
- ZLAB N/A
- EPS
- PRKS 3.77
- ZLAB N/A
- Revenue
- PRKS $1,707,446,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- PRKS $0.91
- ZLAB $41.80
- Revenue Next Year
- PRKS $2.35
- ZLAB $49.93
- P/E Ratio
- PRKS $13.59
- ZLAB N/A
- Revenue Growth
- PRKS N/A
- ZLAB 32.56
- 52 Week Low
- PRKS $37.68
- ZLAB $23.82
- 52 Week High
- PRKS $60.83
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- PRKS 46.88
- ZLAB 27.79
- Support Level
- PRKS $49.69
- ZLAB $27.81
- Resistance Level
- PRKS $52.03
- ZLAB $29.77
- Average True Range (ATR)
- PRKS 1.77
- ZLAB 1.25
- MACD
- PRKS -0.24
- ZLAB -0.46
- Stochastic Oscillator
- PRKS 31.26
- ZLAB 1.20
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.